VOCATIV

LEXINGTON, Mass. — “I’m a frickin’ pioneer, man,” Kevin Hrusovksy, CEO of Quanterix said. “I see the opportunity to eliminate pain and suffering . . . and we’re going to do it.”

The revolutionary work is happening in a nondescript corporate office where a dozen armoire-sized automated boxes glean minute protein biomarkers in blood samples with unprecedented sensitivity.

Blood tests could soon diagnose concussions—and even the onset of chronic traumatic encephalopathy, CTE, a neurodegenerative disease that has afflicted many former football players—and do so objectively within as little as 20 minutes.

Read the remainder of the article at Vocativ.